Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature

被引:13
|
作者
Reynaert, Hendrik [1 ,2 ]
Colle, Isabelle [3 ,4 ]
机构
[1] UZBrussel, Dept Gastroenterol Hepatol, Laarbeeklaan 101, B-1090 Brussels, Belgium
[2] Vrije Univ Brussel, Liver Cell Biol Lab, Laarbeeklaan 103, B-1090 Brussels, Belgium
[3] ASZ Aalst, Dept Gastroenterol Hepatol, Merestr 80, B-9300 Aalst, Belgium
[4] Univ Ghent, Dept Gastroenterol Hepatol, Pintelaan, B-9000 Ghent, Belgium
关键词
hepatocellular carcinoma; octreotide; somatostatin; somatostatin analogues; somatostatin receptor; LONG-ACTING OCTREOTIDE; RECEPTOR SUBTYPES; PLUS OCTREOTIDE; PLACEBO; MULTICENTER; EXPRESSION; TUMOR; PROLIFERATION; PASIREOTIDE; SORAFENIB;
D O I
10.3390/ijms20194811
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma, one of the most dreaded complications of cirrhosis, is a frequent cancer with high mortality. Early primary liver cancer can be treated by surgery or ablation techniques, but advanced hepatocellular carcinoma remains a challenge for clinicians. Most of these patients have underlying cirrhosis, which complicates or even precludes treatment. Therefore, efficacious treatments without major side effects are welcomed. Initial results of treatment of advanced hepatocellular carcinoma with somatostatin analogues were promising, but subsequent trials have resulted in conflicting outcomes. This might be explained by different patient populations, differences in dosage and type of treatment and differences in somatostatin receptor expression in the tumor or surrounding tissue. It has been shown that the expression of somatostatin receptors in the tumor might be of importance to select patients who could benefit from treatment with somatostatin analogues. Moreover, somatostatin receptor expression in hepatocellular carcinoma has been shown to correlate with recurrence, prognosis, and survival. In this review, we will summarize the available data on treatment of primary liver cancer with somatostatin analogues and analyze the current knowledge of somatostatin receptor expression in hepatocellular carcinoma and its possible clinical impact.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Treatment of hepatocellular carcinoma with long acting somatostatin analogues
    Samonakis, DN
    Moschandreas, J
    Arnaoutis, T
    Skordilis, P
    Leontidis, C
    Vafiades, I
    Kouroumalis, E
    ONCOLOGY REPORTS, 2002, 9 (04) : 903 - 907
  • [2] The role of somatostatin analogues in the treatment of advanced malignant thymomas: case report and review of the literature
    Pettit, L.
    El-Modir, A.
    BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (997): : E7 - E10
  • [3] Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?
    Kouroumalis, Elias
    Tsomidis, Ioannis
    Voumvouraki, Argryro
    LIVERS, 2022, 2 (04): : 315 - 335
  • [4] Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials
    Ji, Xi-Qing
    Ruan, Xin-Jian
    Chen, Hong
    Chen, Gang
    Li, Shi-Yong
    Yu, Bo
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : RA169 - RA176
  • [5] Mechanisms of Action and Resistance of Somatostatin Analogues for the Treatment of Hepatocellular Carcinoma: A Message Not Well Taken
    Dimitrios N. Samonakis
    George Notas
    Nikolaos Christodoulakis
    Elias A. Kouroumalis
    Digestive Diseases and Sciences, 2008, 53 : 2359 - 2365
  • [6] Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: A message not well taken
    Samonakis, Dimitrios N.
    Notas, George
    Christodoulakis, Nikolaos
    Kouroumalis, Elias A.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (09) : 2359 - 2365
  • [7] MET inhibitors for treatment of advanced hepatocellular carcinoma: A review
    Qi, Xing-Shun
    Guo, Xiao-Zhong
    Han, Guo-Hong
    Li, Hong-Yu
    Chen, Jiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (18) : 5445 - 5453
  • [8] The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
    Schipilliti, Francesca Matilde
    Garajova, Ingrid
    Rovesti, Giulia
    Balsano, Rita
    Piacentini, Federico
    Dominici, Massimo
    Gelsomino, Fabio
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 17
  • [9] MET inhibitors for treatment of advanced hepatocellular carcinoma: A review
    Xing-Shun Qi
    Xiao-Zhong Guo
    Guo-Hong Han
    Hong-Yu Li
    Jiang Chen
    World Journal of Gastroenterology, 2015, (18) : 5445 - 5453
  • [10] Assessment of treatment response in hepatocellular carcinoma: a review of the literature
    Maida, Marcello
    Cabibbo, Giuseppe
    Brancatelli, Giuseppe
    Genco, Chiara
    Alessi, Nicola
    Genova, Claudio
    Romano, Piero
    Raineri, Maurizio
    Giarratano, Antonello
    Midiri, Massimo
    Camma, Calogero
    FUTURE ONCOLOGY, 2013, 9 (06) : 845 - 854